Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “oxcarbazepine”

16 pharma patents match "oxcarbazepine" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 16
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 16 pharmaceutical patents matching "oxcarbazepine" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

16 results for “oxcarbazepine” · 30,257 patents in full index Clear search

  1. US 11896599

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted Feb 13, 2024 · Expires Feb 8, 2044

    granted
  2. US 11166960

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted
  3. US 10220042

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted Mar 5, 2019 · Expires Feb 28, 2039

    granted
  4. US 9855278

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted
  5. US 9370525

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted
  6. US 9351975

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted May 31, 2016 · Expires May 26, 2036

    granted
  7. US 9119792

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted
  8. US 9119791

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted
  9. US 8821930

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted
  10. US 8617600

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted
  11. US 8211464

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted
  12. US 8017149

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted Sep 13, 2011 · Expires Sep 8, 2031

    granted
  13. US 7910131

    Method of treating seizures using modified release formulations of oxcarbazepine

    Supernus Pharmaceuticals, Inc. · Granted Mar 22, 2011 · Expires Mar 17, 2031

    granted
  14. US 7722898

    Modified-release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted May 25, 2010 · Expires May 20, 2030

    granted
  15. AU 2007242062

    Pharmaceutical compositions of oxcarbazepine with a median particle size of 15 to 30 microns

    ALPHAPHARM PTY LTD [AU] · Granted Nov 1, 2007 · Expires Oct 27, 2027

    granted
  16. US 7183272

    Crystal forms of oxcarbazepine and processes for their preparation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 27, 2007 · Expires Feb 22, 2027

    granted